07:51 AM EDT, 10/28/2025 (MT Newswires) -- NeoGenomics ( NEO ) reported Q3 adjusted earnings Tuesday of $0.03 per diluted share, down from $0.05 a year earlier.

Analysts surveyed by FactSet expected $0.02.

Net revenue for the quarter ended Sept. 30 was $187.8 million, up from $167.8 million a year earlier.

Analysts polled by FactSet expected $183.7 million.

The company said it continues to expect 2025 adjusted EPS in the range of $0.08 to $0.12 on revenue of $720 million to $726 million. Analysts polled by FactSet expect $0.09 and $723.5 million, respectively.

NeoGenomics ( NEO ) shares were up 6.2% in recent premarket activity.